🇺🇸 FDA
Patent

US 7566732

Rhodanine compositions for use as antiviral agents

granted A61KA61K31/40A61K31/41

Quick answer

US patent 7566732 (Rhodanine compositions for use as antiviral agents) held by Rigel Pharmaceuticals, Inc. expires Mon Jul 23 2029 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Rigel Pharmaceuticals, Inc.
Grant date
Tue Jul 28 2009 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 23 2029 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
3
CPC classes
A61K, A61K31/40, A61K31/41, A61K31/4166, A61K31/421